The client is a publicly traded, international biotechnology company. The company specializes in the creation and development of differentiated antibody therapies for cancer.
The company chose Infosys as their partner for SAP S/4HANA implementation. The objective of the engagement was to build a solid ERP platform that would support rapid commercial growth and deliver the capabilities for modern user experience and consolidated financial reporting.
Ready to experience?TALK TO EXPERTS
Infosys implemented a digital transformation initiative, leveraging the core capabilities of SAP S/4HANA. The program covered the following processes and functions at the client’s global locations:
The digital transformation program was aimed at designing and implementing a digital ERP platform with standardized business processes, while adopting SAP and industry best practices. The key objective was to maximize effectiveness, minimize cost, and provide a competitive advantage to the company. The Infosys team achieved this by implementing an integrated solution with key internal and external applications. This improved both reporting and decision-making.
Digital integrated ERP platform for future business growth
Process optimization and standardization across the business
Significant reduction in financial closure time during month-end and quarter-end financial closure cycles
Easier reporting with excellent user experience and real-time analytical reports, using SAP Fiori
Increased operational efficiency through integration and automation with bank and suppliers
Validated environment that fulfils SOX compliance and various other regulatory requirements